Close Menu

HIV

Benitec Biopharma said this week that it has non-exclusively licensed its expressed RNAi technology to Calimmune for use in developing an RNAi-based HIV/AIDS treatment.

Siemens Inks New Companion Dx Collaborations with ViiV Healthcare, Tocagen

This story originally ran on Dec. 22.
By Adam Bonislawski

Scientists from PATH and the US Centers for Disease Control will collaborate under a three-year grant from the National Institutes of Health to further develop and test a non-instrumented DNA amplification kit for diagnosing diseases in resource-poor areas of the world, according

By Adam Bonislawski
Virginia Tech scientists have developed an algorithm that uses protein interaction data to make predictions about the function of individual molecules.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.